COVID-19 Impact on Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Substance Use Disorders (SUDs) Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Substance Use Disorders (SUDs) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Opioid Addiction
  • 1.4.3 Tobacco/Nicotine Addiction
  • 1.4.4 Alcohol Dependence
• 1.5 Market by Application
  • 1.5.1 Global Substance Use Disorders (SUDs) Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital & Clinics
  • 1.5.3 Residential (non-hospital)
• 1.6 Coronavirus Disease 2019 (Covid-19): Substance Use Disorders (SUDs) Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Substance Use Disorders (SUDs) Treatment Industry
    • 1.6.1.1 Substance Use Disorders (SUDs) Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Substance Use Disorders (SUDs) Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Substance Use Disorders (SUDs) Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Substance Use Disorders (SUDs) Treatment Market Perspective (2015-2026)
• 2.2 Substance Use Disorders (SUDs) Treatment Growth Trends by Regions
  • 2.2.1 Substance Use Disorders (SUDs) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Substance Use Disorders (SUDs) Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Substance Use Disorders (SUDs) Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Substance Use Disorders (SUDs) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Substance Use Disorders (SUDs) Treatment Players by Market Size
  • 3.1.1 Global Top Substance Use Disorders (SUDs) Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Substance Use Disorders (SUDs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Substance Use Disorders (SUDs) Treatment Market Concentration Ratio
  • 3.2.1 Global Substance Use Disorders (SUDs) Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Substance Use Disorders (SUDs) Treatment Revenue in 2019
• 3.3 Substance Use Disorders (SUDs) Treatment Key Players Head office and Area Served
• 3.4 Key Players Substance Use Disorders (SUDs) Treatment Product Solution and Service
• 3.5 Date of Enter into Substance Use Disorders (SUDs) Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Substance Use Disorders (SUDs) Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Type (2021-2026)

5 Substance Use Disorders (SUDs) Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)
• 5.2 Global Substance Use Disorders (SUDs) Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 6.2 Substance Use Disorders (SUDs) Treatment Key Players in North America (2019-2020)
• 6.3 North America Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 6.4 North America Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 7.2 Substance Use Disorders (SUDs) Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 7.4 Europe Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 8.2 Substance Use Disorders (SUDs) Treatment Key Players in China (2019-2020)
• 8.3 China Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 8.4 China Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 9.2 Substance Use Disorders (SUDs) Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 9.4 Japan Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 10.2 Substance Use Disorders (SUDs) Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 11.2 Substance Use Disorders (SUDs) Treatment Key Players in India (2019-2020)
• 11.3 India Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 11.4 India Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Substance Use Disorders (SUDs) Treatment Market Size (2015-2020)
• 12.2 Substance Use Disorders (SUDs) Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Indivior
  • 13.1.1 Indivior Company Details
  • 13.1.2 Indivior Business Overview and Its Total Revenue
  • 13.1.3 Indivior Substance Use Disorders (SUDs) Treatment Introduction
  • 13.1.4 Indivior Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020))
  • 13.1.5 Indivior Recent Development
• 13.2 Pfizer
  • 13.2.1 Pfizer Company Details
  • 13.2.2 Pfizer Business Overview and Its Total Revenue
  • 13.2.3 Pfizer Substance Use Disorders (SUDs) Treatment Introduction
  • 13.2.4 Pfizer Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.2.5 Pfizer Recent Development
• 13.3 Alkermes
  • 13.3.1 Alkermes Company Details
  • 13.3.2 Alkermes Business Overview and Its Total Revenue
  • 13.3.3 Alkermes Substance Use Disorders (SUDs) Treatment Introduction
  • 13.3.4 Alkermes Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.3.5 Alkermes Recent Development
• 13.4 Novartis
  • 13.4.1 Novartis Company Details
  • 13.4.2 Novartis Business Overview and Its Total Revenue
  • 13.4.3 Novartis Substance Use Disorders (SUDs) Treatment Introduction
  • 13.4.4 Novartis Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.4.5 Novartis Recent Development
• 13.5 Mylan
  • 13.5.1 Mylan Company Details
  • 13.5.2 Mylan Business Overview and Its Total Revenue
  • 13.5.3 Mylan Substance Use Disorders (SUDs) Treatment Introduction
  • 13.5.4 Mylan Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.5.5 Mylan Recent Development
• 13.6 Cipla
  • 13.6.1 Cipla Company Details
  • 13.6.2 Cipla Business Overview and Its Total Revenue
  • 13.6.3 Cipla Substance Use Disorders (SUDs) Treatment Introduction
  • 13.6.4 Cipla Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.6.5 Cipla Recent Development
• 13.7 Glenmark
  • 13.7.1 Glenmark Company Details
  • 13.7.2 Glenmark Business Overview and Its Total Revenue
  • 13.7.3 Glenmark Substance Use Disorders (SUDs) Treatment Introduction
  • 13.7.4 Glenmark Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.7.5 Glenmark Recent Development
• 13.8 Dr. Reddy's Laboratories
  • 13.8.1 Dr. Reddy's Laboratories Company Details
  • 13.8.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
  • 13.8.3 Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Introduction
  • 13.8.4 Dr. Reddy's Laboratories Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.8.5 Dr. Reddy's Laboratories Recent Development
• 13.9 Teva Pharmaceutical
  • 13.9.1 Teva Pharmaceutical Company Details
  • 13.9.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  • 13.9.3 Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Introduction
  • 13.9.4 Teva Pharmaceutical Revenue in Substance Use Disorders (SUDs) Treatment Business (2015-2020)
  • 13.9.5 Teva Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer